Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

OncoCyte Corp buy krebskrebs

OncoCyte Corp
Start price
€2.58
15.11.21 / 50%
Target price
€4.00
15.11.22
Performance (%)
-86.43%
End price
€0.35
16.11.22
Summary
This prediction ended on 16.11.22 with a price of €0.35. The BUY prediction by krebskrebs for OncoCyte Corp performed very badly with a performance of -86.43%. krebskrebs has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
OncoCyte Corp - - - -
iShares Core DAX® -1.212% 1.925% 17.589% 68.786%
iShares Nasdaq 100 -4.714% -1.810% 0.450% 100.066%
iShares Nikkei 225® -2.976% -2.660% 10.156% 43.024%
iShares S&P 500 -2.744% -0.448% 0.320% 63.222%

Comments by krebskrebs for this prediction

In the thread OncoCyte Corp diskutieren
Prediction Buy
Perf. (%) -86.43%
Target price 4.000
Change
Ends at

Buy mit Kursziel 4,0

krebskrebs 
0
Report Share
15.11.21
In the thread Trading OncoCyte Corp
Prediction Buy
Perf. (%) -86.43%
Target price 4.000
Change
Ends at 15.11.22

Die von krebskrebs gewählte maximale Laufzeit wurde überschritten

krebskrebs 
0
Report Share
16.11.22